Charles River Laboratories | CRL - Market Capitalization


Charles River Laboratories reported $13.38B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Align Technology USD 12.08B 198M Jun/2026
Bio-Rad Laboratories USD 7.56B 81M Aug/2026
Bruker USD 7.63B 1.54B Aug/2026
Cardinal Health USD 49.72B 894M Mar/2026
Charles River Laboratories USD 13.38B 2.98B Aug/2026
Cigna USD 72.93B 2.59B Jun/2026
Concord Medical Services Hldg CNY 201.89M 84.69M Aug/2026
CVS Health USD 123.52B 8.47B Aug/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.32B 36M Mar/2026
Elevance Health USD 83.98B 19.68B Jun/2026
Humana USD 47.69B 26.88B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
Incyte USD 26.84B 4.19B Aug/2026
IQVIA Holdings USD 42.66B 10.41B Aug/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 109.12B 3.13B Aug/2026
Merck EUR 46.78B 6.52B Mar/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 143.89B 5.44B Aug/2026
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Revvity USD 13.76B 1.07B Aug/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
United Therapeutics USD 24.41B 780M Aug/2026
UnitedHealth USD 377.45B 131.84B Jun/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 23.45B 13.79B Aug/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026